A RANDOMIZED CONTROLLED TRIAL OF PROSTATAK AS ADJUVANT TO UP-FRONT RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Liss, Michael A

Funded by

ADVANTAGENE, INC.

Research Start Date

11/01/2020

Status

Active

Collaborative Project

Clinical Care

Drug Discovery

Cancer

Bioscience Research Panel